NFA
ADMS

Nationwide Fund Advisors’s Adamas Pharmaceuticals ADMS Stock Holding History

Nationwide Fund Advisors’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-8,068
Closed -$171K – 2527
2017
Q3 		$171K Sell
8,068
-871
-10% -$16K ﹤0.01% 2703
2017
Q2 		$156K Sell
8,939
-655
-7% -$10.8K ﹤0.01% 2736
2017
Q1 		$168K Sell
9,594
-1,256
-12% -$21.4K ﹤0.01% 2664
2016
Q4 		$183K Hold
10,850
– – ﹤0.01% 2644
2016
Q3 		$178K Hold
10,850
– – ﹤0.01% 2681
2016
Q2 		$164K Sell
10,850
-13,217
-55% -$218K ﹤0.01% 2704
2016
Q1 		$348K Buy
24,067
+17,444
+263% +$294K ﹤0.01% 2278
2015
Q4 		$188K Hold
6,623
– – ﹤0.01% 2590
2015
Q3 		$111K Hold
6,623
– – ﹤0.01% 2856
2015
Q2 		$174K Buy
6,623
+4,434
+203% +$86.2K ﹤0.01% 2779
2015
Q1 		$38K Hold
2,189
– – ﹤0.01% 3133
2014
Q4 		$38K Hold
2,189
– – ﹤0.01% 3053
2014
Q3 		$41K Buy
2,189
+125
+6% +$2.15K ﹤0.01% 3116
2014
Q2 		$38K Buy
+2,064
New +$37K ﹤0.01% 3116

Other funds holding ADMS

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BWCA
Brenner West Capital Advisors New York $804M AUM 16.19% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Nationwide Fund Advisors's ADMS Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Adamas Pharmaceuticals (ADMS) in Q4 2017, closing a stake of 8,068 shares — an estimated $171K sold.

Nationwide Fund Advisors first reported a position in ADMS in Q2 2014 and held it in 14 quarters. The position peaked at $348K in Q1 2016. 117 funds tracked by Wall St. Rank hold ADMS as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Adamas Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 8,068 Adamas Pharmaceuticals shares in Q4 2017, an estimated $171K.
  • Nationwide Fund Advisors first reported a position in Adamas Pharmaceuticals in Q2 2014 and held it in 14 quarters.
  • Nationwide Fund Advisors's Adamas Pharmaceuticals position peaked at $348K in Q1 2016.
  • 117 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.